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Obesity is associated with a low-grade systemic chronic inﬂammatory state, characterized by the abnormal production of pro-
and anti-inﬂammatory adipocytokines. It has been found that immune cells such as macrophages can inﬁltrate adipose tissue and
are responsible for the majority of inﬂammatory cytokine production. Obesity-induced inﬂammation is considered a potential
mechanism linking obesity to its related pathologies, such as insulin resistance, cardiovascular diseases, type-2 diabetes, and
some immune disorders. Therefore, targeting obesity-related inﬂammatory components may be a useful strategy to prevent or
ameliorate the development of such obesity-related diseases. It has been shown that several food components can modulate
inﬂammatory responses in adipose tissue via various mechanisms, some of which are dependent on peroxisome proliferator-
activated receptor γ (PPARγ), whereas others are independent on PPARγ, by attenuating signals of nuclear factor-κB( N F - κB)
and/orc-Junamino-terminalkinase(JNK).Inthisreview,weintroducethebeneﬁcialeﬀectsofanti-inﬂammatoryphytochemicals
that can help prevent obesity-induced inﬂammatory responses and pathologies.
1.Introduction
Recently, more and more lines of evidence have accumulated
that obesity is associated with low-grade chronic inﬂamma-
tion that is causally involved in the development of insulin
resistance. Systemic inﬂammation is markedly evident in a
number of human and mouse models of obesity, as deter-
mined by increased plasma levels of inﬂammatory cytokines
such as tumor necrosis factor-α (TNF-α), interleukin-6
(IL-6), and monocyte chemoattractant protein-1 (MCP-
1). These inﬂammatory cytokines are derived from obese
adipose tissue [1], and recently, it has been found that not
only adipocytes, but also immune cells, such as macrophages
[2, 3] reside in adipose tissue, and that these cells may
induce insulin resistance by promoting inﬂammation in
these tissues. The major cause of the development of obesity
and the consequent inﬂammatory disorders is the excess
dietary fat intake or an imbalance between the intake and
expenditure of energy. Overweight and obese patients may
develop paradoxical nutritional deﬁciency from eating high
energy foods with poor nutrient content; however, diet
with a higher nutrient density reduces their weight and
improves obesity-related inﬂammatory disorders [4]. This
indicatesthatobesity-relatedpathologiescanbepreventedor
improved by the intake of food containing components that
can control inﬂammation in obese adipose tissues inﬁltrated
with macrophages. In activated macrophages, inﬂammatory
responses are regulated by master regulators of inﬂammation
suchasnuclearfactor-κB(NF -κB)andc-Junamino-terminal
kinase (JNK) [5, 6]. Moreover, peroxisome proliferator-
activatedreceptor-γ (PPARγ)isreportedtoattenuateinﬂam-
mation in activated macrophages by interfering with NF-
κB signaling [7]. Therefore, targeting these inﬂammatory
regulators using food components may be a useful strategy
to prevent or ameliorate the development of obesity-related
diseases. Our group and other research groups have shown
that several food components can modulate inﬂammatory
responses in adipose tissue via various mechanisms, some of2 Mediators of Inﬂammation
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Figure 1: The development of vicious cycle of inﬂammation between adipocytes and macrophages in obese adipose tissue.
which are dependent on PPARγ, whereas others are PPARγ-
independent, by attenuating NF-κB or JNK signaling. In
this review, we introduce the beneﬁcial eﬀects of anti-
inﬂammatory food components against obesity-induced
inﬂammatory responses and pathologies.
2. Inﬂammatory Components Associatedwith
ObesityandRelatedPathologies
Adipose tissue is composed of adipocytes and stromal vascu-
lar cells containing various cell types such as preadipocytes,
endothelial cells, ﬁbroblasts, and numerous immune cells.
In particular, macrophage inﬁltration into adipose tissue is
prominent in obesity, and the number of macrophages in
adipose tissue correlates with body mass index, adipose size,
and the total amount of body fat [2, 3]. It has been suggested
that adipose tissue-derived MCP-1, a CC chemokine that
exhibits chemotactic properties on inﬂammatory cells, is
the key factor for inducing macrophage inﬁltration into
adipose tissue. The level of MCP-1 released by adipocytes
is signiﬁcantly greater in obese mice than in nonobese
mice [8–10] and is markedly increased when adipocytes
a r ec o c u l t u r e dw i t hm a c r o p h a g e s[ 11, 12]. MCP-1 from
hypertrophic adipocytes in obese adipose tissue can also
trigger macrophage inﬁltration into adipose tissue and
subsequently activates macrophages to release inﬂammatory
mediators such as TNF-α [10], which interferes with insulin
signaling and induces fatty acid lipolysis in adipocytes. The
concentrations of these fatty acids, particularly saturated free
fatty acids, are reported to be elevated in obesity [13]a n d
directly induce inﬂammatory responses in macrophages via
toll-like receptor 4 (TLR4), the lipopolysaccharide receptor
[14, 15]. The NF-κB and JNK pathways represent important
modulators of inﬂammatory gene expression downstream of
TLR4 in many cell types, including macrophages [11, 16,
17]. In this way, adipocytes and macrophages interact in a
paracrine manner and create a vicious cycle of inﬂammation
that augments the inﬂammatory changes and insulin resis-
tance in obese adipose tissue [11] (Figure 1).
3. Strategy to Prevent Inﬂammatory Responses
andInsulinResistance inObese Adipose
Tissues by Food Components
Inﬂammatory responses in obese adipose tissues are regu-
lated by many transcriptional factors. NF-κBa n dJ N Kr e p r e -
sent important modulators of inﬂammatory gene expression
downstream of TLR4 in adipose tissues, suggesting that food
components interfering with the TLR4/NF-κB or TLR4/JNK
axis could be useful to prevent the onset of insulin resistance
in obese patients (Figure 2).
Furthermore, PPARγ, a member of the nuclear receptor
superfamilyactivatedbyligands,alsoplaysanimportantrole
in inﬂammation [18, 19]. Thiazolidinediones (TZDs), syn-
thetic ligands for PPARγ, suppress the production of proin-
ﬂammatory cytokines including TNF-α in LPS-stimulated
macrophages [7]. In addition to the anti-inﬂammatory
eﬀect,TZDsregulatethe mRNAexpression ofgenesinvolved
in lipid metabolism in macrophages and suppress their
transformation into foam cells [7, 20]. On the other hand,Mediators of Inﬂammation 3
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Figure 2: Signaling pathway of inﬂammatory gene expressions in obese adipose tissue and the strategy to prevent the obese-related
pathologies by food components.
TZDs have been widely used as antidiabetic drugs, which
activate PPARγ to resulting in the promotion of adipocyte
diﬀerentiation [21]. TZDs not only stimulate glucose uptake
into diﬀerentiated adipocytes but also induce the production
of adiponectin, an insulin-sensitivity-promoting factor [22],
and suppression of TNF-α through the PPARγ activation
in adipocytes [23]. Thus, food components that act as
ligands for PPARγ can show multiple eﬀects, including anti-
diabetes and anti-inﬂammatory eﬀects. Currently, two dif-
ferent molecular mechanisms have been proposed by which
the anti-inﬂammatory actions of PPARγ are in eﬀect: (1)
via interference with proinﬂammatory transcription factors
including NF-κB[ 7], and (2) by preventing the removal of
corepressor complexes from gene promoter regions resulting
in the suppression of inﬂammatory gene transcription [24].
4. Food Components That Regulate
Inﬂammation in Obese Adipose Tissue
On the basis of the strategy suggested above, our research
group focused on the PPARγ-dependent or PPARγ-
independent mechanisms to suppress the inﬂammatory
mediators secreted by obese adipose tissues. For the screen-
ing of food components related to the former mechanism,
our research group used the sensitive PPARγ ligand assay
system developed by modifying the luciferase reporter assay
system [25] and has found several phytochemicals that act
as PPARγ agonists (Table 1). To evaluate the characteristics
offoodcomponentsthatpreventobesity-induced inﬂamma-
tory responses, we used the coculture system of adipocytes
andmacrophages,whichisaninvitromodelofobeseadipose
tissue inﬁltrated by macrophages (Figure 3).
Table 1: Phytochemicals that regulate obesity-induced inﬂamma-
tion.
Compound Origin PPARγ dependency
Abietic acid Pine rosin dependent
Anthocyanin Red/Purplish
Fruit independent
Auraptene Citrus Fruit dependent
Capsaicin Hot pepper dependent
Dehydroabietic acid Pine rosin dependent
Diosgenin Fenugreek, Yam independent
6-Gingerol Ginger independent
Isohumulone Humulus lupulus
hop dependent
Isoprenoid Herb dependent
Luteolin Herb, Spice independent
Naringenin Citrus Fruit independent
Naringenin chalcone Tomato peel independent
PUFA Fish oil independent
Resveratrol Red wine dependent
6-Shogaol Ginger dependent
4.1. PPARγ-Dependent Action. Spices are derived from
plants cultivated in temperate and tropical zones, and many
of them have antioxidant, anticancer, antiobesity, and anti-
inﬂammatory activities [26–28]. Several anti-inﬂammatory
spice-derived components are reported to modulate inﬂam-
matory responses in adipose tissue and therefore improve
obesity-related pathologies such as insulin resistance [29,
30].4 Mediators of Inﬂammation
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Figure 3: Coculture system of adipocytes and macrophages for the screening for anti-inﬂammatory food components.
Capsaicin, a spicy ingredient of hot peppers, has not
only metabolic properties to induce thermogenesis and fat
oxidation [26, 28] but also anti-inﬂammatory properties
[31]. In the adipose tissue or adipocyte culture system,
capsaicin inhibits the expression and secretion of IL-6 and
MCP-1 from the adipose tissues and adipocytes of obese
mice, whereas it enhances the expressions of the adiponectin
gene and protein [29]. These actions of capsaicin are asso-
ciated with NF-κB inactivation, which is probably mediated
by PPARγ activation [29]. Moreover, capsaicin suppresses
not only macrophage migration induced in an adipose-
tissue-conditioned medium but also its activation to release
proinﬂammatory mediators. It is also demonstrated that
capsaicin administration in vivo improves obesity-induced
insulin resistance [29].
Ginger, which is the rhizome of the plant Zingiber ofﬁci-
nale Roscoe, is widely used as a spice and herbal medicine.
6-Shogaol is the main ginger-derived component, which
has potent anti-inﬂammatory activities [32, 33]. Because 6-
shogaol is a potent agonist of PPARγ,i tn o to n l ye n h a n c e s
the expressions of adiponectin and aP2 but also inhibits the
TNF-α-induced downregulation of adiponectin expression
in adipocytes [34].
Isoprenoids (terpenoids), which are present in many
dietary and herbal plants [35], exhibit many biological
eﬀects: antitumor proliferation, anti-hypercholesteremia,
and anti-diabetes [35–37]. Abietic acid (AA) and one of
its derivatives, dehydroabietic acid (DAA), are diterpenes,
which are both the major components of the rosin fraction
of oleoresin synthesized by conifer species, such as grand ﬁr
(Abies grandis) and lodgepole pine (Pinus contorta)[ 38]. We
have found that both AA and DAA have anti-inﬂammatory
eﬀects on macrophages, which are mediated by PPARγ
activation [25]. When DAA was administered with a high-fat
diet to obese diabetic KK-Ay mice, DAA suppressed the
production of proinﬂammatory mediators such as MCP-
1a n dT N F - α, increased that of adiponectin, and reduced
the inﬁltration of macrophages into the adipose tissues of
HFD-fed mice [39]. DAA can also strongly activate PPARα,
which is mainly involved in the control of lipid metabolism
[40], and the fact that PPARα agonists such as Wy-14643
can suppress inﬂammation in adipose tissues [41] suggests
that DAA as a PPARα/γ dual agonist is a valuable medic-
inal food-derived component for improving the inﬂam-
mation caused by obesity and for controlling metabolic
syndrome.
Auraptene (a monoterpene derivative), a citrus fruit
compound contained mainly in the peel, is also a PPARα/γ
dual agonist [42, 43]. In adipocytes, auraptene regulates the
transcription of PPARγ target genes, induces the expression
and secretion of adiponectin, and inhibits those of MCP-
1[ 42]. It is also observed that auraptene can suppress the
inﬂammatory changes between adipocytes and macrophages
and the macrophage inﬁltration into obese adipose tissues
(Lin et al. unpublished data). Several reports have indi-
cated that coapplication of PPARα and PPARγ agonists or
treatment with dual agonists causes more eﬃcient glucose
uptake into adipocytes to decrease the blood glucose level
without the increase in body weight [41, 44]. Further in vivo
investigations are necessary to elucidate the inhibitory eﬀect
of auraptene on chronic systemic inﬂammation induced by
obesity.
4.2. PPARγ-Independent Action. Flavonoid is a general term
for plant metabolites that have a C6-C3-C6 structure.
Chalcone is the ﬁrst product in the ﬂavonoid biosynthesisMediators of Inﬂammation 5
pathway, which is catalyzed by chalcone isomerase, resulting
in the ﬂavanone naringenin. Most ﬂavonoids are then
metabolized to ﬂavone, dihydroﬂavonol, ﬂavonol, leucoan-
thocyanidin, catechin, and anthocyanidin by oxidation-
reduction reaction. Over 4,000 ﬂavonoids have been iden-
tiﬁed, many of which occur in vegetables and fruits. These
ﬂavonoids have been reported to have antiviral, antiallergic,
antiplatelet, anti-inﬂammatory, antitumor, and antioxidant
activities, and recently, they have attracted considerable
interestbecauseoftheirpotentialbeneﬁcialeﬀectsonobesity
and metabolic syndromes.
Luteolin, a ﬂavone that is present in medicinal plants and
in some vegetables and spices, has been reported to exhibit
antioxidant, anti-inﬂammatory, and antiallergy functions
[45]. Recently, we have found that luteolin also inhibits low-
grade chronic inﬂammation induced during the coculture of
adipocytes and macrophages [17]. Luteolin does not aﬀect
I-κB-α degradation and thus may not aﬀect the NF-κB
activation. However, it inhibits the phosphorylation of JNK
in the macrophages activated by the conditioned medium
derived from adipocytes [17]. Because luteolin is not a
PPARγ agonist (Ando et al. unpublished data), luteolin may
act on JNK directly or indirectly via a PPARγ-independent
mechanism.
Using the coculture system of adipocytes and macro-
phages, we have also found similar eﬀects of naringenin
chalcone, a type of ﬂavonoid accumulated in tomato peels.
Naringenin chalcone has only been reported as having
antiallergic activities [46]; therefore, we examined its eﬀect
on the inﬂammatory changes associated with the interaction
of adipocytes and macrophages. As in the case of lute-
olin, naringenin chalcone also suppresses the production
of inﬂammatory mediators induced by the coculture of
adipocytesandmacrophages[12].Theﬂavanonenaringenin,
which is abundant in citrus fruits, also inhibits coculture-
induced inﬂammation; however, the suppressive eﬀect is
more notable in naringenin chalcone [12]. However, unlike
luteolin, naringenin chalcone and naringenin partly inhibit
the degradation of I-κB-α [12] and suppress the macrophage
inﬁltration to hypertrophied adipocytes (Hirai et al. unpub-
lished data). These three ﬂavonoids do not serve as agonists
of PPARγ in the luciferase reporter assay (Hirai et al. unpub-
lished data); thus, it is considered that they also aﬀectthe sig-
naling molecules downstream of TLR4 directly or indirectly
but independently of PPARγ activation in macrophages.
Anthocyanins, another type of ﬂavonoid found in
red/purplish fruits and vegetables, including purple grapes,
apples, blueberries, egg apples, and beans, are well-known
antioxidants. These ﬂavonoids have also been shown to
have anti-inﬂammatory activity in obese adipose tissues,
which is mediated by PPARγ-independent mechanisms
[47, 48]. Moreover, cyanidin 3-glucoside (C3G), a typical
anthocyanin, downregulates the retinol binding protein 4,
which is known to ameliorate insulin sensitivity in the white
adipose tissue of diabetic KK-Ay mice [49]. Therefore, the
C3G-induced improvement of insulin sensitivity may be
associated with the inhibition of inﬂammatory mediators
and stimulation of AMPK activity via PPARγ-independent
mechanisms [48].
Aside from ﬂavonoids, a saponin aglycon, diosgenin, is
also found to suppress the inﬂammatory mediators induced
bytheinteractionofadipocytesandmacrophages.Diosgenin
is found in a variety of plants including fenugreek (Trigonella
foenum-graecum) and roots of wild yam (Dioscorea villosa),
and its extracts have been traditionally used to treat diabetes
[50] and hypercholesterolemia [51]. Many researchers have
shown that diosgenin has various biological functions,
including anti-inﬂammation [52]. In our coculture system,
diosgenin also inhibited the inﬂammatory changes via the
downregulation of I-κB-α degradation and JNK activation
[53], which is independent of PPARγ activation (Uemura et
al. unpublished data).
6-Gingerol is another main ginger-derived component
besides 6-shogaol. The structures of these two components
are very similar and both are reported to inhibit TNF-α-
mediated suppressionofadiponectin in adipocytes; however,
the mechanisms of their inhibitory eﬀects are diﬀerent;
6-gingerol inhibits JNK signaling pathways in TNF-α-
induced adipocytes without aﬀecting PPARγ transactiva-
tion, whereas the anti-inﬂammatory action of 6-shogaol
is PPARγ-dependent [54]. These results suggest that slight
structural diﬀerences may aﬀect the aﬃnity for PPARγ and
the inhibition of the JNK signaling pathways.
Although saturated fatty acids directly induce inﬂamma-
tory responses in macrophages, long-chain ω-3 polyunsat-
urated fatty acids (PUFAs), such as docosahexaenoic acid
(DHA) and eicosapentaenoic acid (EPA), are known as
antiobesity and anti-inﬂammatory factors. Fish oil contain-
ing high concentrations of DHA and EPA is considered
a good source of ω-3 PUFA. The prevention of high-fat
or high-energy-diet-induced adipose tissue inﬂammation
and remodeling by long-chain ω-3 PUFA is reported to
be involved in PPARγ activation [55, 56]. However, the
anti-inﬂammatory mechanisms of PUFA action are diverse
and involve PPARγ-independent eﬀects [57]. Furthermore,
PUFA needs many cofactors such as folic acid, vitamins,
tetrahydrobiopterin, minerals, and L-arginine for their
physiological actions [58]. Hence, these cofactors should
also be provided in adequate amounts to bring about the
anti-inﬂammatory actions of ω-3 PUFA in obese adipose
tissues.
5. Conclusions/Outlook
A growing number of studies strongly support that obesity-
induced inﬂammation plays an important role in the
development of obesity-related pathologies such as insulin
resistance, cardiovascular diseases, type-2 diabetes, and
some immune disorders. NF-κB and JNK are important
modulators of inﬂammatory gene expression downstream
of TLR4 in obese adipose tissues, which are regulated
by PPARγ. All the food components described above are
beneﬁcial phytochemicals that ameliorate obesity-induced
inﬂammatory responses and pathologies by suppressing the
inﬂammatory signaling in a PPARγ-dependent or PPARγ-
independent manner. In particular, PPARγ agonists can
directly reduce adipocyte size and induce the expression
of anti-inﬂammatory cytokines, such as adiponectin [23].6 Mediators of Inﬂammation
Moreover, PPARγ agonists have recently been reported to
cause the polarization of adipose tissue macrophages to M2
phenotypes, resulting in the secretion of anti-inﬂammatory
cytokines [59]. Thus, food components with PPARγ ago-
nistic activities may also contribute to the improvement of
obesity-induced inﬂammation via adipose tissue remodeling
associated with the phenotype switch of macrophages.
Recently,ithasbeenreportedthatacombinationofbioactive
compounds is very eﬀective in vivo [60]. In particular, a
combinationofcompoundsexhibitingdiﬀerentmechanisms
by which anti-inﬂammatory eﬀects are exerted seems to be
most eﬃcient. Therefore, all the described phytochemicals
in this review, which act as PPARγ agonists, may be suitable
for the treatment of metabolic syndrome together with other
compounds that can suppress inﬂammatory responses in
aP P A R γ-independent manner, by directly inhibiting NF-
κB or JNK signaling. As shown in Table 1, citrus fruits
including oranges, grapefruits, lemons, and some limes,
and ﬁsh oil from blue-skin ﬁsh such as sardine, herring,
and albacore tuna, are the most available anti-inﬂammatory
foods in the market. On the other hand, our daily intake
of spices and herbs are still limited. Further studies on the
eﬀective amounts and forms of intake will help promote the
development of all these functional foods in the world.
References
[1] G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman,
“Adipose expression of tumor necrosis factor-α: direct role in
obesity-linked insulin resistance,” Science, vol. 259, no. 5091,
pp. 87–91, 1993.
[2] S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L.
Leibel, and A. W. Ferrante Jr., “Obesity is associated with
macrophage accumulation in adipose tissue,” The Journal of
Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003.
[3] H. Xu, G. T. Barnes, Q. Yang, et al., “Chronic inﬂammation in
fat plays a crucial role in the development of obesity-related
insulin resistance,” Journal of Clinical Investigation, vol. 112,
no. 12, pp. 1821–1830, 2003.
[ 4 ]T .P .M a r k o v i ca n dS .J .N a t o l i ,“ P a r a d o x i c a ln u t r i t i o n a l
deﬁciency in overweight and obesity: the importance of
nutrient density,” The Medical Journal of Australia, vol. 190,
no. 3, pp. 149–151, 2009.
[ 5 ]M .C .A r k a n ,A .L .H e v e n e r ,F .R .G r e t e n ,e ta l . ,“ I K K - β links
inﬂammation to obesity-induced insulin resistance,” Nature
Medicine, vol. 11, no. 2, pp. 191–198, 2005.
[6] G. Solinas, C. Vilcu, J. G. Neels, et al., “JNK1 in hematopoi-
etically derived cells contributes to diet-induced inﬂamma-
tion and insulin resistance without aﬀecting obesity,” Cell
Metabolism, vol. 6, no. 5, pp. 386–397, 2007.
[7] M. Ricote, A. C. Li, T. M. Willson, C. J. Kelly, and C. K.
Glass, “The peroxisome proliferator-activated receptor-γ is a
negativeregulatorofmacrophageactivation,”Nature,vol.391,
no. 6662, pp. 79–82, 1998.
[8] J. N. Fain, A. K. Madan, M. L. Hiler, P. Cheema, and S. W.
Bahouth, “Comparison of the release of adipokines by adipose
tissue, adipose tissue matrix, and adipocytes from visceral and
subcutaneous abdominal adipose tissues of obese humans,”
Endocrinology, vol. 145, no. 5, pp. 2273–2282, 2004.
[9] J. M. Bruun, A. S. Lihn, S. B. Pedersen, and B. Richelsen,
“Monocyte chemoattractant protein-1 release is higher in
visceral than subcutaneous human adipose tissue (AT): impli-
cation of macrophages resident in the AT,” The Journal of
Clinical Endocrinology and Metabolism,v o l .9 0 ,n o .4 ,p p .
2282–2289, 2005.
[10] R. Yu, C.-S. Kim, B.-S. Kwon, and T. Kawada, “Mesenteric
adipose tissue-derived monocyte chemoattractant protein-1
plays a crucial role in adipose tissue macrophage migration
andactivationinobesemice,”Obesity,vol.14,no.8,pp.1353–
1362, 2006.
[11] T. Suganami, J. Nishida, and Y. Ogawa, “A paracrine loop
between adipocytes and macrophages aggravates inﬂamma-
tory changes: role of free fatty acids and tumor necrosis factor
α,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25,
no. 10, pp. 2062–2068, 2005.
[12] S. Hirai, Y.-I. Kim, T. Goto, et al., “Inhibitory eﬀect of narin-
genin chalcone on inﬂammatory changes in the interaction
between adipocytes and macrophages,” Life Sciences, vol. 81,
no. 16, pp. 1272–1279, 2007.
[13] G. Boden, “Role of fatty acids in the pathogenesis of insulin
resistance and NIDDM,” Diabetes, vol. 46, no. 1, pp. 3–10,
1997.
[14] J. Y. Lee, K. H. Sohn, S. H. Rhee, and D. Hwang, “Saturated
fatty acids, but not unsaturated fatty acids, induce the
expression of cyclooxygenase-2 mediated through toll-like
receptor 4,” The Journal of Biological Chemistry, vol. 276, no.
20, pp. 16683–16689, 2001.
[15] T. Suganami, K. Tanimoto-Koyama, J. Nishida, et al., “Role of
the toll-like receptor 4/NF-κB pathway in saturated fatty acid-
induced inﬂammatory changes in the interaction between
adipocytes and macrophages,” Arteriosclerosis, Thrombosis,
and Vascular Biology, vol. 27, no. 1, pp. 84–91, 2007.
[16] H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.
S. Flier, “TLR4 links innate immunity and fatty acid-induced
insulin resistance,” Journal of Clinical Investigation, vol. 116,
no. 11, pp. 3015–3025, 2006.
[17] C. Ando, N. Takahashi, S. Hirai, et al., “Luteolin, a food-
derived ﬂavonoid, suppresses adipocyte-dependent activation
of macrophages by inhibiting JNK activation,” FEBS Letters,
vol. 583, no. 22, pp. 3649–3654, 2009.
[18] G. Chinetti, J.-C. Fruchart, and B. Staels, “Peroxisome
proliferator-activated receptors (PPARs): nuclear receptors at
the crossroads between lipid metabolism and inﬂammation,”
Inﬂammation Research, vol. 49, no. 10, pp. 497–505, 2000.
[19] C. K. Glass, “Potential roles of the peroxisome proliferator-
activated receptor-γ in macrophage biology and atheroscle-
rosis,” Journal of Endocrinology, vol. 169, no. 3, pp. 461–464,
2001.
[20] K. J. Moore, E. D. Rosen, M. L. Fitzgerald, et al., “The
role of PPAR-γ in macrophage diﬀerentiation and cholesterol
uptake,” Nature Medicine, vol. 7, no. 1, pp. 41–47, 2001.
[21] B.M.Spiegelman,“Peroxisomeproliferator-activatedreceptor
γ: a key regulator of adipogenesis and systemic insulin
sensitivity,” European Journal of Medical Research, vol. 2, no.
11, pp. 457–464, 1997.
[22] N. Maeda, I. Shimomura, K. Kishida, et al., “Diet-induced
insulin resistance in mice lacking adiponectin/ACRP30,”
Nature Medicine, vol. 8, no. 7, pp. 731–737, 2002.
[23] T. Yamauchi, J. Kamon, H. Waki, et al., “The mechanisms
bywhichbothheterozygousperoxisomeproliferator-activated
receptor γ (PPARγ) deﬁciency and PPARγ agonist improve
insulin resistance,” The Journal of Biological Chemistry, vol.
276, no. 44, pp. 41245–41254, 2001.
[24] G. Pascual, A. L. Fong, S. Ogawa, et al., “A SUMOylation-
dependent pathway mediates transrepression of inﬂammatoryMediators of Inﬂammation 7
response genes by PPAR-γ,” Nature, vol. 437, no. 7059, pp.
759–763, 2005.
[25] N. Takahashi, T. Kawada, T. Goto, et al., “Dual action of
isoprenols from herbal medicines on both PPARγ and PPARα
in 3T3-L1 adipocytes and HepG2 hepatocytes,” FEBS Letters,
vol. 514, no. 2-3, pp. 315–322, 2002.
[26] T. Kawada, T. Watanabe, and T. Takaishi, “Capsaicin-induced
β-adrenergic action on energy metabolism in rats: inﬂuence
ofcapsaicin onoxygen consumption, therespiratoryquotient,
and substrate utilization,” Proceedings of the Society for Exper-
imental Biology and Medicine, vol. 183, no. 2, pp. 250–256,
1986.
[27] Y.-J. Surh, “Anti-tumor promoting potential of selected spice
ingredients with antioxidative and anti-inﬂammatory activi-
ties: a short review,” Food and Chemical Toxicology, vol. 40, no.
8, pp. 1091–1097, 2002.
[28] M. Westerterp-Plantenga, K. Diepvens, A. M. C. P. Joosen, S.
B´ erub´ e-Parent, and A. Tremblay, “Metabolic eﬀects of spices,
teas, and caﬀeine,” Physiology & Behavior,v o l .8 9 ,n o .1 ,p p .
85–91, 2006.
[29] J.-H. Kang, C.-S. Kim, I.-S. Han, T. Kawada, and R. Yu,
“Capsaicin, a spicy component of hot peppers, modulates
adipokine gene expression and protein release from obese-
mouse adipose tissues and isolated adipocytes, and suppresses
the inﬂammatory responses of adipose tissue macrophages,”
FEBS Letters, vol. 581, no. 23, pp. 4389–4396, 2007.
[30] H.-M. Woo, J.-H. Kang, T. Kawada, H. Yoo, M.-K. Sung, and
R. Yu, “Active spice-derived components can inhibit inﬂam-
matory responses of adipose tissue in obesity by suppressing
inﬂammatory actions of macrophages and release of mono-
cytechemoattractantprotein-1fromadipocytes,”LifeSciences,
vol. 80, no. 10, pp. 926–931, 2007.
[31] C.-S. Kim, T. Kawada, B.-S. Kim, et al., “Capsaicin exhibits
anti-inﬂammatory property by inhibiting IkB-a degradation
in LPS-stimulated peritoneal macrophages,” Cellular Sig-
nalling, vol. 15, no. 3, pp. 299–306, 2003.
[32] A. S. A. Levy, O. Simon, J. Shelly, and M. Gardener, “6-
Shogaol reduced chronic inﬂammatory response in the knees
of rats treated with complete Freund’s adjuvant,” BMC
Pharmacology, vol. 6, article 12, 2006.
[33] J. A. Ojewole, “Analgesic, antiinﬂammatory and hypogly-
caemic eﬀects of ethanol extract of Zingiber oﬃcinale
(Roscoe) rhizomes (Zingiberaceae) in mice and rats,” Phy-
totherapy Research, vol. 20, no. 9, pp. 764–772, 2006.
[34] Y. Isa, Y. Miyakawa, M. Yanagisawa, et al., “6-Shogaol and
6-gingerol, the pungent of ginger, inhibit TNF-α mediated
downregulation of adiponectin expression via diﬀerent mech-
anisms in 3T3-L1 adipocytes,” Biochemical and Biophysical
Research Communications, vol. 373, no. 3, pp. 429–434, 2008.
[35] C. E. Elson, G. L. Underbakke, P. Hanson, E. Shrago, R. H.
Wainberg, and A. A. Qureshi, “Impact of lemongrass oil, an
essential oil, on serum cholesterol,” Lipids,v o l .2 4 ,n o .8 ,p p .
677–679, 1989.
[36] L. He, H. Mo, S. Hadisusilo, A. A. Qureshi, and C. E. Elson,
“Isoprenoids suppress the growth of murine B16 melanomas
in vitro and in vivo,” Journal of Nutrition, vol. 127, no. 5, pp.
668–674, 1997.
[37] A. L. Miller, “Dimercaptosuccinic acid (DMSA), a non-toxic,
water-soluble treatment for heavy metal toxicity,” Alternative
Medicine Review, vol. 3, no. 3, pp. 199–207, 1998.
[38] F. J. Aranda and J. Villala´ ın, “The interaction of abietic acid
withphospholipidmembranes,”BiochimicaetBiophysicaActa,
vol. 1327, no. 2, pp. 171–180, 1997.
[39] M.-S. Kang, S. Hirai, T. Goto, et al., “Dehdroabietic acid,a
diterpene improves diabetes and hyperlipdemia in obese
diabitic KK-Ay mice,” BioFactors, vol. 35, no. 5, pp. 442–448,
2009.
[40] M.-S. Kang, S. Hirai, T. Goto, et al., “Dehydroabietic acid,
a phytochemical, acts as ligand for PPARs in macrophages
and adipocytes to regulate inﬂammation,” Biochemical and
Biophysical Research Communications, vol. 369, no. 2, pp. 333–
338, 2008.
[41] A. Tsuchida, T. Yamauchi, S. Takekawa, et al., “Peroxisome
proliferator-activated receptor (PPAR)α activation increases
adiponectin receptors and reduces obesity-related inﬂamma-
tion in adipose tissue: comparison of activation of PPARα,
PPARγ, and their combination,” Diabetes, vol. 54, no. 12, pp.
3358–3370, 2005.
[42] K. Kuroyanagi, M.-S. Kang, T. Goto, et al., “Citrus auraptene
acts as an agonist for PPARs and enhances adiponectin
production and MCP-1 reduction in 3T3-L1 adipocytes,”
Biochemical and Biophysical Research Communications, vol.
366, no. 1, pp. 219–225, 2008.
[43] N. Takahashi, M.-S. Kang, K. Kuroyanagi, et al., “Auraptene, a
citrus fruit compound, regulates gene expression as a PPARα
agonist in HepG2 hepatocytes,” BioFactors,v o l .3 3 ,n o .1 ,p p .
25–32, 2008.
[44] S. Sharma, A. Sowjanya, M. Kumari, et al., “Biochemical
mechanism of insulin sensitization, lipid modulation and
anti-atherogenic potential of PPAR α/γ dual agonist: ragagli-
tazar,” Life Sciences, vol. 80, no. 3, pp. 235–244, 2006.
[45] E.MiddletonJr.,C.Kandaswami, andT.C.Theoharides,“The
eﬀects of plant ﬂavonoids on mammalian cells: implications
for inﬂammation, heart disease, and cancer,” Pharmacological
Reviews, vol. 52, no. 4, pp. 673–751, 2000.
[46] T. Yamamoto, M. Yoshimura, F. Yamaguchi, et al., “Anti-
allergic activity of naringenin chalcone from a tomato skin
extract,” Bioscience, Biotechnology and Biochemistry, vol. 68,
no. 8, pp. 1706–1711, 2004.
[47] T. Tsuda, F. Horio, K. Uchida, H. Aoki, and T. Osawa, “Dietary
cyanidin 3-O-β-D-glucoside-rich purple corn color prevents
obesity and ameliorates hyperglycemia in mice,” Journal of
Nutrition, vol. 133, no. 7, pp. 2125–2130, 2003.
[48] T. Tsuda, “Regulation of adipocyte function by anthocyanins;
possibility of preventing the metabolic syndrome,” Journal of
Agricultural and Food Chemistry, vol. 56, no. 3, pp. 642–646,
2008.
[49] R. Sasaki, N. Nishimura, H. Hoshino, et al., “Cyanidin 3-
glucoside ameliorates hyperglycemia and insulin sensitivity
due to downregulation of retinol binding protein 4 expression
in diabetic mice,” Biochemical Pharmacology, vol. 74, no. 11,
pp. 1619–1627, 2007.
[50] Z. Madar, R. Abel, S. Samish, and J. Arad, “Glucose-lowering
eﬀect of fenugreek in non-insulin dependent diabetics,”
European Journal of Clinical Nutrition, vol. 42, no. 1, pp. 51–
54, 1988.
[51] G. Valette, Y. Sauvaire, J. C. Baccou, and G. Ribes, “Hypoc-
holesterolaemic eﬀect of fenugreek seeds in dogs,” Atheroscle-
rosis, vol. 50, no. 1, pp. 105–111, 1984.
[52] F.-L.ChiuandJ.-K.Lin,“TomatidineinhibitsiNOSandCOX-
2 through suppression of NF-κB and JNK pathways in LPS-
stimulated mouse macrophages,” FEBS Letters, vol. 582, no.
16, pp. 2407–2412, 2008.
[53] S. Hirai, T. Uemura, N. Mizoguchi, et al., “Diosgenin atten-
uates inﬂammatory changes in the interaction between
adipocytes and macrophages,” Molecular Nutrition and Food
Research. In press.8 Mediators of Inﬂammation
[54] Y. Isa, Y. Miyakawa, M. Yanagisawa, et al., “6-Shogaol and
6-gingerol, the pungent of ginger, inhibit TNF-α mediated
downregulation of adiponectin expression via diﬀerent mech-
anisms in 3T3-L1 adipocytes,” Biochemical and Biophysical
Research Communications, vol. 373, no. 3, pp. 429–434, 2008.
[55] J. Todoric, M. L¨ oﬄer, J. Huber, et al., “Adipose tissue
inﬂammation induced by high-fat diet in obese diabetic mice
is prevented by n-3 polyunsaturated fatty acids,” Diabetologia,
vol. 49, no. 9, pp. 2109–2119, 2006.
[56] J. Huber, M. L¨ oﬄer, M. Bilban, et al., “Prevention of high-
fat diet-induced adipose tissue remodeling in obese diabetic
mice by n-3 polyunsaturated fatty acids,” InternationalJournal
of Obesity, vol. 31, no. 6, pp. 1004–1013, 2007.
[57] T. M. Stulnig, “Immunomodulation by polyunsaturated fatty
acids: mechanisms and eﬀects,” International Archives of
Allergy and Immunology, vol. 132, no. 4, pp. 310–321, 2003.
[58] U. N. Das, “Folic acid says NO to vascular diseases,” Nutrition,
vol. 19, no. 7-8, pp. 686–692, 2003.
[59] R. Stienstra, C. Duval, S. Keshtkar, J. Van Der Laak, S. Kersten,
and M. M¨ uller, “Peroxisome proliferator-activated receptor
γ activation promotes inﬁltration of alternatively activated
macrophages into adipose tissue,” The Journal of Biological
Chemistry, vol. 283, no. 33, pp. 22620–22627, 2008.
[60] S. Kiokias and M. H. Gordon, “Dietary supplementation
with a natural carotenoid mixture decreases oxidative stress,”
European Journal of ClinicalNutrition, vol. 57, no. 9, pp.1135–
1140, 2003.